Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2026 Filed Mar 5, 2026 21:55 UTC |
Humeau LaurentChief Scientific Officer
|
GrantCommon Stock Option · Derivative | 26,840 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001770390-26-000003 · wk-form4_1772747737.xml · derivative · entry 1 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,840 Underlying: Common Stock · 26,840 shares Expires 2036-02-26 F1 · derivative.exercise_date: The vesting schedule for the 26,840 options granted on March 4, 2026 was as follows: 8,947 shares will vest on February 26, 2027; 8,947 shares will vest on February 26, 2028; 8,946 shares will vest on February 26, 2029. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 21:55 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
GrantRestricted Stock Unit · Derivative | 78,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001771498-26-000003 · wk-form4_1772747707.xml · derivative · entry 2 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,760 Underlying: Common Stock · 78,760 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 78,760 restricted stock units granted on March 4, 2026 was as follows: 26,254 shares will vest on February 26, 2027; 26,253 shares will vest on February 26, 2028; and 26,253 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 78,760 restricted stock units granted on March 4, 2026 was as follows: 26,254 shares will vest on February 26, 2027; 26,253 shares will vest on February 26, 2028; and 26,253 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 78,760 restricted stock units granted on March 4, 2026 was as follows: 26,254 shares will vest on February 26, 2027; 26,253 shares will vest on February 26, 2028; and 26,253 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 21:55 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
GrantCommon Stock Option · Derivative | 97,240 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001771498-26-000003 · wk-form4_1772747707.xml · derivative · entry 1 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,240 Underlying: Common Stock · 97,240 shares Expires 2036-02-26 F1 · derivative.exercise_date: The vesting schedule for the 97,240 options granted on March 4, 2026 was as follows: 32,414 shares will vest on February 26, 2027; 32,413 shares will vest on February 26, 2028; 32,413 shares will vest on February 26, 2029. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 21:54 UTC |
Sumner Michael JohnChief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 29,608 | $0.00 | $0.00 |
DisclosureSEC source: 0001936799-26-000003 · wk-form4_1772747679.xml · derivative · entry 2 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,608 Underlying: Common Stock · 29,608 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 29,608 restricted stock units granted on March 4, 2026 was as follows: 9,870 shares will vest on February 26, 2027; 9,869 shares will vest on February 26, 2028; and 9,869 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 29,608 restricted stock units granted on March 4, 2026 was as follows: 9,870 shares will vest on February 26, 2027; 9,869 shares will vest on February 26, 2028; and 9,869 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 29,608 restricted stock units granted on March 4, 2026 was as follows: 9,870 shares will vest on February 26, 2027; 9,869 shares will vest on February 26, 2028; and 9,869 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 21:54 UTC |
Sumner Michael JohnChief Medical Officer
|
GrantCommon Stock Option · Derivative | 36,832 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001936799-26-000003 · wk-form4_1772747679.xml · derivative · entry 1 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,832 Underlying: Common Stock · 36,832 shares Expires 2036-02-26 F1 · derivative.exercise_date: The vesting schedule for the 36,832 options granted on March 4, 2026 was as follows: 12,278 shares will vest on February 26, 2027; 12,277 shares will vest on February 26, 2028; 12,277 shares will vest on February 26, 2029. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 21:54 UTC |
KIES PETERCFO
|
GrantRestricted Stock Unit · Derivative | 25,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001259780-26-000004 · wk-form4_1772747645.xml · derivative · entry 2 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,520 Underlying: Common Stock · 25,520 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 25,520 restricted stock units granted on March 4, 2026 was as follows: 8,507 shares will vest on February 26, 2027; 8,507 shares will vest on February 26, 2028; and 8,506 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 25,520 restricted stock units granted on March 4, 2026 was as follows: 8,507 shares will vest on February 26, 2027; 8,507 shares will vest on February 26, 2028; and 8,506 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 25,520 restricted stock units granted on March 4, 2026 was as follows: 8,507 shares will vest on February 26, 2027; 8,507 shares will vest on February 26, 2028; and 8,506 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 21:54 UTC |
KIES PETERCFO
|
GrantCommon Stock Option · Derivative | 31,240 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001259780-26-000004 · wk-form4_1772747645.xml · derivative · entry 1 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,240 Underlying: Common Stock · 31,240 shares Expires 2036-02-26 F1 · derivative.exercise_date: The vesting schedule for the 31,240 options granted on March 4, 2026 was as follows: 10,414 shares will vest on February 26, 2027; 10,413 shares will vest on February 26, 2028; 10,413 shares will vest on February 26, 2029. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:49 UTC |
Humeau LaurentChief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,366 | $0.00 | $0.00 |
DisclosureSEC source: 0001770390-26-000002 · wk-form4_1772228940.xml · derivative · entry 6 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,732 Underlying: Common Stock · 7,366 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 22,098 restricted stock units granted on February 27, 2025 was as follows: 7,366 shares vested on February 26, 2026; 7,366 shares will vest on February 26, 2027; 7,366 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 22,098 restricted stock units granted on February 27, 2025 was as follows: 7,366 shares vested on February 26, 2026; 7,366 shares will vest on February 26, 2027; 7,366 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 22,098 restricted stock units granted on February 27, 2025 was as follows: 7,366 shares vested on February 26, 2026; 7,366 shares will vest on February 26, 2027; 7,366 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:49 UTC |
Humeau LaurentChief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001770390-26-000002 · wk-form4_1772228940.xml · derivative · entry 5 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,009 Underlying: Common Stock · 5,010 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:49 UTC |
Humeau LaurentChief Scientific Officer
|
Tax withholdingCommon Stock | 3,034 | $1.79 | $5,430.86 |
DisclosureSEC source: 0001770390-26-000002 · wk-form4_1772228940.xml · nonDerivative · entry 4 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,900 F4 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:49 UTC |
Humeau LaurentChief Scientific Officer
|
Exercise / conversionCommon Stock | 7,366 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001770390-26-000002 · wk-form4_1772228940.xml · nonDerivative · entry 3 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 22,098 restricted stock units granted on February 27, 2025 was as follows: 7,366 shares vested on February 26, 2026; 7,366 shares will vest on February 26, 2027; 7,366 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:49 UTC |
Humeau LaurentChief Scientific Officer
|
Tax withholdingCommon Stock | 2,064 | $1.79 | $3,694.56 |
DisclosureSEC source: 0001770390-26-000002 · wk-form4_1772228940.xml · nonDerivative · entry 2 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,568 F2 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:49 UTC |
Humeau LaurentChief Scientific Officer
|
Exercise / conversionCommon Stock | 5,010 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001770390-26-000002 · wk-form4_1772228940.xml · nonDerivative · entry 1 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,632 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:48 UTC |
KIES PETERCFO
|
Exercise / conversionRestricted Stock Unit · Derivative | 10,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001259780-26-000002 · wk-form4_1772228904.xml · derivative · entry 7 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,266 Underlying: Common Stock · 10,634 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 31,900 restricted stock units granted on February 27, 2025 was as follows: 10,634 shares vested on February 26, 2026; 10,633 shares will vest on February 26, 2027; 10,633 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 31,900 restricted stock units granted on February 27, 2025 was as follows: 10,634 shares vested on February 26, 2026; 10,633 shares will vest on February 26, 2027; 10,633 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 31,900 restricted stock units granted on February 27, 2025 was as follows: 10,634 shares vested on February 26, 2026; 10,633 shares will vest on February 26, 2027; 10,633 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:48 UTC |
KIES PETERCFO
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001259780-26-000002 · wk-form4_1772228904.xml · derivative · entry 6 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,009 Underlying: Common Stock · 5,010 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:48 UTC |
KIES PETERCFO
|
Tax withholdingCommon Stock | 6,294 | $1.79 | $11,266.26 |
DisclosureSEC source: 0001259780-26-000002 · wk-form4_1772228904.xml · nonDerivative · entry 4 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,642 F4 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:48 UTC |
KIES PETERCFO
|
Exercise / conversionCommon Stock | 10,634 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001259780-26-000002 · wk-form4_1772228904.xml · nonDerivative · entry 3 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 31,900 restricted stock units granted on February 27, 2025 was as follows: 10,634 shares vested on February 26, 2026; 10,633 shares will vest on February 26, 2027; 10,633 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:48 UTC |
KIES PETERCFO
|
Tax withholdingCommon Stock | 2,965 | $1.79 | $5,307.35 |
DisclosureSEC source: 0001259780-26-000002 · wk-form4_1772228904.xml · nonDerivative · entry 2 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,302 F2 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:48 UTC |
KIES PETERCFO
|
Exercise / conversionCommon Stock | 5,010 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001259780-26-000002 · wk-form4_1772228904.xml · nonDerivative · entry 1 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,267 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:47 UTC |
Sumner Michael JohnChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001936799-26-000002 · wk-form4_1772228830.xml · derivative · entry 5 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,100 Underlying: Common Stock · 11,550 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 34,650 restricted stock units granted on February 27, 2025 was as follows: 11,550 shares vested on February 26, 2026; 11,550 shares will vest on February 26, 2027; 11,550 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 34,650 restricted stock units granted on February 27, 2025 was as follows: 11,550 shares vested on February 26, 2026; 11,550 shares will vest on February 26, 2027; 11,550 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 34,650 restricted stock units granted on February 27, 2025 was as follows: 11,550 shares vested on February 26, 2026; 11,550 shares will vest on February 26, 2027; 11,550 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:47 UTC |
Sumner Michael JohnChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001936799-26-000002 · wk-form4_1772228830.xml · derivative · entry 4 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,009 Underlying: Common Stock · 5,010 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:47 UTC |
Sumner Michael JohnChief Medical Officer
|
Tax withholdingCommon Stock | 3,903 | $1.79 | $6,986.37 |
DisclosureSEC source: 0001936799-26-000002 · wk-form4_1772228830.xml · nonDerivative · entry 3 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,507 F3 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (2) herein. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:47 UTC |
Sumner Michael JohnChief Medical Officer
|
Exercise / conversionCommon Stock | 11,550 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001936799-26-000002 · wk-form4_1772228830.xml · nonDerivative · entry 2 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,410 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 34,650 restricted stock units granted on February 27, 2025 was as follows: 11,550 shares vested on February 26, 2026; 11,550 shares will vest on February 26, 2027; 11,550 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:47 UTC |
Sumner Michael JohnChief Medical Officer
|
Exercise / conversionCommon Stock | 5,010 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001936799-26-000002 · wk-form4_1772228830.xml · nonDerivative · entry 1 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,860 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:47 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 28,401 | $0.00 | $0.00 |
DisclosureSEC source: 0001771498-26-000002 · wk-form4_1772228868.xml · derivative · entry 6 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,800 Underlying: Common Stock · 28,401 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 85,201 restricted stock units granted on February 27, 2025 was as follows: 28,401 shares vested on February 26, 2026; 28,400 shares will vest on February 26, 2027; 28,400 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 85,201 restricted stock units granted on February 27, 2025 was as follows: 28,401 shares vested on February 26, 2026; 28,400 shares will vest on February 26, 2027; 28,400 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 85,201 restricted stock units granted on February 27, 2025 was as follows: 28,401 shares vested on February 26, 2026; 28,400 shares will vest on February 26, 2027; 28,400 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:47 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 18,632 | $0.00 | $0.00 |
DisclosureSEC source: 0001771498-26-000002 · wk-form4_1772228868.xml · derivative · entry 5 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,631 Underlying: Common Stock · 18,632 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024 was as follows: 18,632 shares vested on February 26, 2025; 18,632 shares vested on February 26, 2026; and 18,631 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024 was as follows: 18,632 shares vested on February 26, 2025; 18,632 shares vested on February 26, 2026; and 18,631 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024 was as follows: 18,632 shares vested on February 26, 2025; 18,632 shares vested on February 26, 2026; and 18,631 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:47 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 13,657 | $1.79 | $24,446.03 |
DisclosureSEC source: 0001771498-26-000002 · wk-form4_1772228868.xml · nonDerivative · entry 4 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,004 F4 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:47 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 28,401 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001771498-26-000002 · wk-form4_1772228868.xml · nonDerivative · entry 3 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 85,201 restricted stock units granted on February 27, 2025 was as follows: 28,401 shares vested on February 26, 2026; 28,400 shares will vest on February 26, 2027; 28,400 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:47 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 8,057 | $1.79 | $14,422.03 |
DisclosureSEC source: 0001771498-26-000002 · wk-form4_1772228868.xml · nonDerivative · entry 2 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,260 F2 · shares: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:47 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 18,632 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001771498-26-000002 · wk-form4_1772228868.xml · nonDerivative · entry 1 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024 was as follows: 18,632 shares vested on February 26, 2025; 18,632 shares vested on February 26, 2026; and 18,631 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:44 UTC |
Weiner David B.Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 972 | $0.00 | $0.00 |
DisclosureSEC source: 0001669080-26-000002 · wk-form4_1772228657.xml · derivative · entry 2 Weiner David B. · CIK 0001669080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 972 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units granted on February 27, 2023 was as follows: 972 shares vested on February 26, 2024; 972 shares vested on February 26, 2025; and 972 shares vested on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units granted on February 27, 2023 was as follows: 972 shares vested on February 26, 2024; 972 shares vested on February 26, 2025; and 972 shares vested on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units granted on February 27, 2023 was as follows: 972 shares vested on February 26, 2024; 972 shares vested on February 26, 2025; and 972 shares vested on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:44 UTC |
Weiner David B.Director
|
Exercise / conversionCommon Stock | 972 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001669080-26-000002 · wk-form4_1772228657.xml · nonDerivative · entry 1 Weiner David B. · CIK 0001669080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units granted on February 27, 2023 was as follows: 972 shares vested on February 26, 2024; 972 shares vested on February 26, 2025; and 972 shares vested on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 20:08 UTC |
Sumner Michael JohnChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-25-000046 · wk-form4_1751400477.xml · derivative · entry 2 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,916 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 8,749 restricted stock units was as follows: 2,916 shares vested on June 30, 2023; 2,917 shares vested on June 30, 2024; and 2,916 shares vested on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 8,749 restricted stock units was as follows: 2,916 shares vested on June 30, 2023; 2,917 shares vested on June 30, 2024; and 2,916 shares vested on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 8,749 restricted stock units was as follows: 2,916 shares vested on June 30, 2023; 2,917 shares vested on June 30, 2024; and 2,916 shares vested on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 20:08 UTC |
Sumner Michael JohnChief Medical Officer
|
Exercise / conversionCommon Stock | 2,916 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-25-000046 · wk-form4_1751400477.xml · nonDerivative · entry 1 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 8,749 restricted stock units was as follows: 2,916 shares vested on June 30, 2023; 2,917 shares vested on June 30, 2024; and 2,916 shares vested on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 21, 2025 Filed May 21, 2025 20:58 UTC |
Zoth Lota S.Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-25-000040 · wk-form4_1747861110.xml · derivative · entry 2 Zoth Lota S. · CIK 0001278219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,167 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. Read SEC document |
| May 21, 2025 Filed May 21, 2025 20:58 UTC |
Zoth Lota S.Director
|
Exercise / conversionCommon Stock | 2,167 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-25-000040 · wk-form4_1747861110.xml · nonDerivative · entry 1 Zoth Lota S. · CIK 0001278219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. Read SEC document |
| May 21, 2025 Filed May 21, 2025 20:58 UTC |
Miller Ann CalbyDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-25-000039 · wk-form4_1747861099.xml · derivative · entry 2 Miller Ann Calby · CIK 0001771423 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,167 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. Read SEC document |
| May 21, 2025 Filed May 21, 2025 20:58 UTC |
Miller Ann CalbyDirector
|
Exercise / conversionCommon Stock | 2,167 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-25-000039 · wk-form4_1747861099.xml · nonDerivative · entry 1 Miller Ann Calby · CIK 0001771423 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,877 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. Read SEC document |
| May 21, 2025 Filed May 21, 2025 20:58 UTC |
Shepard JayDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-25-000038 · wk-form4_1747861088.xml · derivative · entry 2 Shepard Jay · CIK 0001587788 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,167 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. Read SEC document |
| May 21, 2025 Filed May 21, 2025 20:58 UTC |
Shepard JayDirector
|
Exercise / conversionCommon Stock | 2,167 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-25-000038 · wk-form4_1747861088.xml · nonDerivative · entry 1 Shepard Jay · CIK 0001587788 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. Read SEC document |
| May 21, 2025 Filed May 21, 2025 20:58 UTC |
BENITO SIMON XDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-25-000037 · wk-form4_1747861076.xml · derivative · entry 2 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,167 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. Read SEC document |
| May 21, 2025 Filed May 21, 2025 20:58 UTC |
BENITO SIMON XDirector
|
Exercise / conversionCommon Stock | 2,167 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-25-000037 · wk-form4_1747861076.xml · nonDerivative · entry 1 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. Read SEC document |
| May 21, 2025 Filed May 21, 2025 20:57 UTC |
YARNO WENDY LDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-25-000036 · wk-form4_1747861066.xml · derivative · entry 2 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,167 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. Read SEC document |
| May 21, 2025 Filed May 21, 2025 20:57 UTC |
YARNO WENDY LDirector
|
Exercise / conversionCommon Stock | 2,167 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-25-000036 · wk-form4_1747861066.xml · nonDerivative · entry 1 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,512 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. Read SEC document |
| May 21, 2025 Filed May 21, 2025 20:57 UTC |
DANSEY ROGER DDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-25-000034 · wk-form4_1747861045.xml · derivative · entry 2 DANSEY ROGER D · CIK 0001741836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,167 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. Read SEC document |
| May 21, 2025 Filed May 21, 2025 20:57 UTC |
DANSEY ROGER DDirector
|
Exercise / conversionCommon Stock | 2,167 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-25-000034 · wk-form4_1747861045.xml · nonDerivative · entry 1 DANSEY ROGER D · CIK 0001741836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,916 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. Read SEC document |
| May 21, 2025 Filed May 21, 2025 20:57 UTC |
Weiner David B.Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-25-000032 · wk-form4_1747861024.xml · derivative · entry 2 Weiner David B. · CIK 0001669080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,167 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. Read SEC document |
| May 21, 2025 Filed May 21, 2025 20:57 UTC |
Weiner David B.Director
|
Exercise / conversionCommon Stock | 2,167 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-25-000032 · wk-form4_1747861024.xml · nonDerivative · entry 1 Weiner David B. · CIK 0001669080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,620 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:58 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
GrantCommon Stock Option · Derivative | 105,262 | $0.00 Strike: $2.13 | $0.00 |
DisclosureSEC source: 0001055726-25-000042 · wk-form4_1747861132.xml · derivative · entry 2 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,262 Underlying: Common Stock · 105,262 shares Expires 2035-05-20 F2 · derivative.exercise_date: The vesting schedule for the 105,262 options is as follows: 52,631 shares will vest on May 20, 2027 and 52,631 shares will vest on May 20, 2028. Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:58 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
GrantRestricted Stock Unit · Derivative | 84,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-25-000042 · wk-form4_1747861132.xml · derivative · entry 1 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,888 Underlying: Common Stock · 84,888 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 84,888 restricted stock units is as follows: 28,296 shares will vest on May 20, 2026; 28,296 shares will vest on May 20, 2027; and 28,296 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 84,888 restricted stock units is as follows: 28,296 shares will vest on May 20, 2026; 28,296 shares will vest on May 20, 2027; and 28,296 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 84,888 restricted stock units is as follows: 28,296 shares will vest on May 20, 2026; 28,296 shares will vest on May 20, 2027; and 28,296 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.